Company News-Bio-Thera Solutions, Ltd.

2025-08-26

Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...

查看详情

05-062024

Bio-Thera Solutions Announces the Launch of TOFIDENCE® (tocilizumab-bavi) in the United States

GUANGZHOU, China - Bio-Thera Solutions (688177.SH), a commercial-stage biopharmaceutical company developinginnovative th...
03-252024

Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor α

Guangzhou, China -- Bio-Thera Solutions(688177:SH), a commercial-stage biopharmaceutical company developing a pipelineof...
03-182024

Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM

GUANGZHOU, China and San José, Costa Rica- Bio-Thera Solutions, a commercial-stagebiopharmaceutical company developing i...